Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Spiration® Valve System (SVS) Post-Market Registry Study for Severe Emphysema

NCT04302272 is registered in ClinicalTrials.gov with Olympus Corporation of the Americas as lead sponsor.

NCT NCT04302272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04302272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Spiration® Valve System (SVS) Post-Market Registry Study for Severe Emphysema
Lead sponsor
Olympus Corporation of the Americas
Phase
Observational
Overall status
Recruiting
Start date
October 9, 2021
Completion date
October 31, 2029
Enrollment
150 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema